Early in her medical career, Dr. Angeline Beltsos made a decision. She realized that while delivering babies was amazing, helping couples conceive was something special and she decided to become a reproductive endocrinologist. She and physicians like her, offer the 70 million infertile couples worldwide hope that they’ll have the opportunity to have a baby.
Over the past 15 years, she’s seen her field advance through increasingly successful assisted reproductive technologies (ART). In vitro fertilization (IVF) methods have improved, and the ability to freeze eggs and embryos without damaging them (vitrification) supports better implantation rates.
To screen embryos for genetic health, Dr. Beltsos and her team at the Fertility Centers of Illinois use preimplantation genetic screening (PGS) tools such as the Illumina 24sure® assay or VeriSeq™ (PGS). In addition to enabling young, infertile couples to have healthy pregnancies, these genomics tools enable women who are over 40 years old or who have miscarried in the past to have IVF performed with embryos that are known to be viable.